Healthcare provider profile · identity verified

Karandeep Singh, MD

Hospitalist · FRESNO, CA · NPI 1659313567

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	546	137
Eliquis	Apixaban	374	49
Levothyroxine Sodium	Levothyroxine Sodium	344	51
Amlodipine Besylate	Amlodipine Besylate	327	79
Gabapentin	Gabapentin	289	75
Furosemide	Furosemide	251	48
Tamsulosin Hcl	Tamsulosin Hcl	226	47
Pantoprazole Sodium	Pantoprazole Sodium	198	53
Mirtazapine	Mirtazapine	186	37
Divalproex Sodium	Divalproex Sodium	165	28
Metformin Hcl	Metformin Hcl	157	35
Metoprolol Tartrate	Metoprolol Tartrate	156	42
Potassium Chloride	Potassium Chloride	137	24
Carvedilol	Carvedilol	136	28
Januvia	Sitagliptin Phosphate	132	17
Losartan Potassium	Losartan Potassium	106	26
Lisinopril	Lisinopril	105	31
Famotidine	Famotidine	102	27
Xarelto	Rivaroxaban	100	16
Duloxetine Hcl	Duloxetine Hcl	97	13
Trazodone Hcl	Trazodone Hcl	96	23
Simvastatin	Simvastatin	92	16
Metoprolol Succinate	Metoprolol Succinate	91	24
Clopidogrel	Clopidogrel Bisulfate	87	18
Finasteride	Finasteride	87	17
Donepezil Hcl	Donepezil Hcl	85	13
Sertraline Hcl	Sertraline Hcl	73	15
Lactulose	Lactulose	68	17
Spironolactone	Spironolactone	66	14
Quetiapine Fumarate	Quetiapine Fumarate	64	18
Omeprazole	Omeprazole	63	21
Glipizide	Glipizide	61	suppressed
Baclofen	Baclofen	56	17
Olanzapine	Olanzapine	56	suppressed
Latanoprost	Latanoprost	55	14
Levetiracetam	Levetiracetam	55	15
Montelukast Sodium	Montelukast Sodium	55	12
Hydralazine Hcl	Hydralazine Hcl	52	21
Fenofibrate	Fenofibrate Nanocrystallized	49	suppressed
Allopurinol	Allopurinol	48	11
Rosuvastatin Calcium	Rosuvastatin Calcium	48	suppressed
Digoxin	Digoxin	47	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	46	23
Carbidopa-Levodopa	Carbidopa/Levodopa	46	suppressed
Tradjenta	Linagliptin	45	suppressed
Amiodarone Hcl	Amiodarone Hcl	43	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	43	suppressed
Midodrine Hcl	Midodrine Hcl	43	11
Heparin Sodium	Heparin Sodium,porcine	41	suppressed
Alendronate Sodium	Alendronate Sodium	40	suppressed
Warfarin Sodium	Warfarin Sodium	36	suppressed
Pregabalin	Pregabalin	34	11
Triamcinolone Acetonide	Triamcinolone Acetonide	34	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	20
Humalog	Insulin Lispro	32	suppressed
Jardiance	Empagliflozin	32	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	29	11
Bumetanide	Bumetanide	27	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	27	19
Pravastatin Sodium	Pravastatin Sodium	27	suppressed
Entresto	Sacubitril/Valsartan	26	suppressed
Klayesta	Nystatin	26	14
Ondansetron Hcl	Ondansetron Hcl	26	18
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	18
Propylthiouracil	Propylthiouracil	25	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	24	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	23	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Nystop	Nystatin	23	13
Risperidone	Risperidone	23	suppressed
Timolol Maleate	Timolol Maleate	22	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	15
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	20	suppressed
Tiotropium Bromide	Tiotropium Bromide	20	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Insulin Lispro	Insulin Lispro	19	suppressed
Levofloxacin	Levofloxacin	19	14
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	18	suppressed
Tramadol Hcl	Tramadol Hcl	18	11
Breyna	Budesonide/Formoterol Fumarate	17	suppressed
Cephalexin	Cephalexin	17	11
Prednisone	Prednisone	17	12
Sucralfate	Sucralfate	17	suppressed
Diltiazem Hcl	Diltiazem Hcl	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Ursodiol	Ursodiol	16	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Linzess	Linaclotide	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Sodium Chloride	0.9 % Sodium Chloride	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Novolog	Insulin Aspart	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Atenolol	Atenolol	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Lurasidone Hcl	Lurasidone Hcl	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Primidone	Primidone	12	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	11	suppressed
Invega Sustenna	Paliperidone Palmitate	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error